Wen Shi is an early career researcher who has an avid interest in humoral immunity against viral infections. He completed his PhD on HIV cure strategies, examining the utility of antibody Fc effector functions against latent HIV infection. He has recently pivoted to work on COVID-19, with a focus on neutralizing antibody responses elicited by vaccination and infection and the development of monoclonal antibody therapeutics against coronavirus infections.
